₨ 5,610.00
MBBS
FIBATIDE 0.75mg Infusion 100ml
- Does this requires a prescription ? Yes
- Generic Name: Eptifibatide:0.75mg + Eptifibatide:0.75mg
- Manufactured by : Global Pharmaceuticals
- Drug Strength : 0.75mg
- Drug Form : Infusion
- Pack Size : 100ml
- Product SKU : dis_21635
Eptifibatide:0.75mg + Eptifibatide:0.75mg | Anticoagulants/Platelet deaggregators
Manufactured / Marketed By : Global Product Form : InfusionPack Size : 100mlIngredients : Eptifibatide:0.75mg + Eptifibatide:0.75mgGeneric Category : Anticoagulants/Platelet deaggregators
How it works
FIBATIDE 0.75mg Infusion 100ml prevents the abnormal formation of blood clots and associated adverse events.
Side effects
Major & minor side effects for FIBATIDE 0.75mg Infusion 100ml
- Abdominal
- Back pain severe
- Bleeding from the bladder severe
- Bleeding gums
- Blood in urine severe
- Bloody or tarry stools severe
- Blurred vision
- Constipation
- Presence of blood in cough severe
- Dizziness when getting up suddenly from a sitting position
- Headache
- Heavy menstrual bleeding severe
- Paralysis severe
- Unusual bleeding or bruising severe
- Shortness of breath
- Unusual tiredness or weakness
- Pinpoint red spots on skin
- Difficulty in swallowing
- Fast/irregular heart beat severe
- Severe skin rash and hives severe
- Puffing or swelling of eyelids rare
- Slurred speech severe
- Inability to move the arms, legs, or facial muscle severe
Uses of FIBATIDE 0.75mg Infusion 100ml
What is it prescribed for?
-
Acute Coronary Syndrome
This medicine is used to decrease the risk of death and a new episode of a heart attack in patients suffering from an acute coronary syndrome, including patients who are to be managed medically and those undergoing percutaneous coronary intervention.
-
Percutaneous Coronary Intervention
This medicine is used to decrease the risk of death, a new episode of a heart attack, or a need for urgent intervention in patients undergoing percutaneous coronary intervention, including those undergoing stenting procedure.
Concerns
Frequently asked questions
-
Onset of action
The effect of this medicine can be observed immediately following an intravenous administration.
-
Duration of Effect
The effect of this medicine lasts for an average duration of 4 to 6 hours.
-
Safe with Alchohol?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
-
Is it habit forming?
No habit-forming tendencies were reported.
-
Usage in pregnancy?
This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.
-
Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.
When not to use?
-
Allergy
This medicine is not recommended for use in patients with a known allergy to FIBATIDE 0.75mg Infusion 100ml or any other inactive ingredients present along with it.
-
Bleeding disorder
This medicine is not recommended for use in patients with a history of bleeding disorders due to blood coagulation issues (bleeding diathesis) or active abnormal bleeding within the previous 30 days due to the increased risk of worsening of the patient’s condition.
-
Severe hypertension
This medicine is not recommended for use in patients suffering from severe hypertension (high blood pressure levels more than 200/110 mm Hg) that is not adequately controlled using appropriate medication due to the increased risk of worsening of the patient’s condition.
-
Major surgery
This medicine is not recommended for use in patients who have undergone major surgery within the preceding 6 weeks due to the increased risk of worsening of the patient’s condition.
-
Stroke
This medicine is not recommended for use in patients with a history of stroke within the past 30 days or any history of hemorrhagic stroke (an emergency condition where blood vessels rupture within the brain) due to the increased risk of worsening of the patient’s condition.
-
GP IIb/IIIa inhibitor
This medicine is not recommended for use in patients receiving or patients about to receive other parenteral GP IIb/IIIa inhibitors since it may worsen the patient's condition.
-
Hemodialysis
This medicine is not recommended for use in patients who are undergoing dialysis or have a dependency on this procedure due to the increased risk of worsening of the patient’s condition.
Warnings
-
Pregnancy
This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.
-
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.
-
Other medicines
This medicine may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.
-
Use in children
This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.
-
Use in elderly
This medicine should be used with caution and monitoring in elderly patients since the risk of severe adverse effects is significantly high.
-
Bleeding test
It is recommended to collect blood samples and test the possibility of unexpected bleeding before and during therapy with this medicine. Patients should always be monitored for signs and symptoms that could indicate unusual or unexpected bleeding.
-
Kidney diseases
This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Regular monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
-
Hypertension
This medicine should be used with caution and monitoring in patients suffering from hypertension (high blood pressure levels). Use is not recommended if the increase in blood pressure level is very high (severe hypertension) and the patient is not receiving appropriate therapy to correct the blood pressure level.
-
Surgery
This medicine is not recommended for use in patients who have undergone major surgery, injury, trauma, or any other medical emergency within the past 6 weeks. Inform your doctor in advance so that the dose regimen with this medicine can be appropriately adjusted.
Dosage
-
Missed Dose
Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.
-
Overdose
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Interactions
Interaction with Medicines- Ubiquinone/Vitamin E moderate
- Dipyridamole severe
- Celecoxib moderate
- Fluoxetine moderate
- Citalopram moderate
- Clopidogrel severe
- Prasugrel severe
- Warfarin severe
- Ibuprofen moderate
- Diclofenac moderate
- Abciximab severe
- Magnesium salicylate moderate
- Tenecteplase severe
General Instructions
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. The dose strength and method of administration are likely to vary based on multiple criteria. You may be asked to frequently undertake certain tests before and during therapy with this medicine. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Other details
- Usage does not depend on food timings
- To be taken as instructed by doctor
- May cause sleepiness
References
- dailymed - EPTIFIBATIDE [Internet]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f48ecd1e-a2c3-45d1-9e2e-d9a8fb71a770 [cited 2/23/2021]. 2019
One of the following licensed pharmacy from the nearest location will deliver FIBATIDE 0.75mg Infusion 100ml. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Related products
Products listed on medicalstore.com.pk are 100% genuine and sourced from licensed pharmacies.
We work hard to bring you unimaginable discounts without compromising on quality.
We uses SSL (standard security technology) to ensure data privacy of all our customers.
Reviews
There are no reviews yet.